Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Batlle

Showing results (121-130 of 155) with videos related to

Pageof 16
Sort By:
Diabetes|June 29, 2006
ACE and ACE2 activity in diabetic miceJan Wysocki, Minghao Ye, Maria José Soler, et al.
Kidney360|January 2, 2026
Transforming the Venous Blood Gas to the Arterial Blood Gas from Concurrent MeasurementsDaniel Batlle, Romy Fischer, Luise Hassler, et al.
Cell|May 27, 2022
Evidence in favor of the essentiality of human cell membrane-bound ACE2 and against soluble ACE2 for SARS-CoV-2 infectivityDaniel Batlle, Vanessa Monteil, Elena Garreta, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 25, 2006
Paricalcitol capsule for the treatment of secondary hyperparathyroidism in stages 3 and 4 CKDDaniel Coyne, Muralidhar Acharya, Ping Qiu, et al.
Hypertension (Dallas, Tex. : 1979)|December 3, 2019
Ang II (Angiotensin II) Conversion to Angiotensin-(1-7) in the Circulation Is POP (Prolyloligopeptidase)-Dependent and ACE2 (Angiotensin-Converting Enzyme 2)-IndependentPeter Serfozo, Jan Wysocki, Gvantca Gulua, et al.
Kidney International|December 14, 2020
Knockout of aminopeptidase A in mice causes functional alterations and morphological glomerular basement membrane changes in the kidneysBenedikt Marahrens, Arndt Schulze, Jan Wysocki, et al.
Advances in Chronic Kidney Disease|January 4, 2007
Stabilization of glomerular filtration rate in advanced chronic kidney disease: a two-year follow-up of a cohort of chronic kidney disease patients stages 4 and 5Andres Serrano, Jie Huang, Cybele Ghossein, et al.
Clinical Journal of the American Society of Nephrology : CJASN|February 11, 2014
Improving CKD therapies and care: a National DialogueFrederick Kaskel, Daniel Batlle, Srinivasan Beddhu, et al.
Physiological Reports|October 13, 2019
Urinary angiotensinogen antedates the development of stage 3 CKD in patients with type 1 diabetes mellitusSheeba Ba Aqeel, Minghao Ye, Jan Wysocki, et al.
Hypertension (Dallas, Tex. : 1979)|May 14, 2019
Urinary Renin in Patients and Mice With Diabetic Kidney DiseaseJeannette Tang, Jan Wysocki, Minghao Ye, et al.
Pageof 16

Showing results (121-130 of 155) with videos related to

Sort By:
Pageof 16
Diabetes|June 29, 2006
ACE and ACE2 activity in diabetic miceJan Wysocki, Minghao Ye, Maria José Soler, et al.
Kidney360|January 2, 2026
Transforming the Venous Blood Gas to the Arterial Blood Gas from Concurrent MeasurementsDaniel Batlle, Romy Fischer, Luise Hassler, et al.
Cell|May 27, 2022
Evidence in favor of the essentiality of human cell membrane-bound ACE2 and against soluble ACE2 for SARS-CoV-2 infectivityDaniel Batlle, Vanessa Monteil, Elena Garreta, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 25, 2006
Paricalcitol capsule for the treatment of secondary hyperparathyroidism in stages 3 and 4 CKDDaniel Coyne, Muralidhar Acharya, Ping Qiu, et al.
Hypertension (Dallas, Tex. : 1979)|December 3, 2019
Ang II (Angiotensin II) Conversion to Angiotensin-(1-7) in the Circulation Is POP (Prolyloligopeptidase)-Dependent and ACE2 (Angiotensin-Converting Enzyme 2)-IndependentPeter Serfozo, Jan Wysocki, Gvantca Gulua, et al.
Kidney International|December 14, 2020
Knockout of aminopeptidase A in mice causes functional alterations and morphological glomerular basement membrane changes in the kidneysBenedikt Marahrens, Arndt Schulze, Jan Wysocki, et al.
Advances in Chronic Kidney Disease|January 4, 2007
Stabilization of glomerular filtration rate in advanced chronic kidney disease: a two-year follow-up of a cohort of chronic kidney disease patients stages 4 and 5Andres Serrano, Jie Huang, Cybele Ghossein, et al.
Clinical Journal of the American Society of Nephrology : CJASN|February 11, 2014
Improving CKD therapies and care: a National DialogueFrederick Kaskel, Daniel Batlle, Srinivasan Beddhu, et al.
Physiological Reports|October 13, 2019
Urinary angiotensinogen antedates the development of stage 3 CKD in patients with type 1 diabetes mellitusSheeba Ba Aqeel, Minghao Ye, Jan Wysocki, et al.
Hypertension (Dallas, Tex. : 1979)|May 14, 2019
Urinary Renin in Patients and Mice With Diabetic Kidney DiseaseJeannette Tang, Jan Wysocki, Minghao Ye, et al.
Pageof 16